Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia–Reperfusion Injury

Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia–Reperfusion Injury

<i>Objective</i>: This study aimed to investigate the cardioprotective effects of bosentan, an endothelin receptor antagonist, in a rat model of lung ischemia–reperfusion (I/R) injury, with a focus on myocardial tissue involvement. <i>Methods</i>: Twenty-four male Wistar rats...

Full description

Saved in:

Bibliographic Details
Main Authors:	Şevki Mustafa Demiröz, Ayşegül Küçük, Esra Tekin, Sibel Söylemez, Hanife Yılmaz, Şaban Cem Sezen, Muharrem Atlı, Hüseyin Demirtaş, Abdullah Özer, Yusuf Ünal, Mustafa Arslan
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Medicina
Subjects:	bosentan lung ischemia–reperfusion cardioprotection oxidative stress endothelin-1 myocardial injury
Online Access:	https://www.mdpi.com/1648-9144/61/7/1298
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of bosentan therapy in persistent pulmonary hypertension of the newborn
by: Gunlawadee Maneenil, et al.
Published: (2018-02-01)

THE EFFICIENCY OF BOSENTAN BASED ON THE DATA OF THE REGISTER OF PATIENTS WITH PULMONARY HYPERTENSION IN THE VORONEZH REGION
by: O. M. Korolkova
Published: (2017-06-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: V. M. Paramonov, et al.
Published: (2016-06-01)

Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial
by: Mandana Kashaki, et al.
Published: (2025-01-01)

A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
by: Hadi Zare-Zardini, et al.
Published: (2024-12-01)

POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
by: M. G. Bubnova
Published: (2013-02-01)

Mechanisms of the cardioprotective effect of lithium
by: A. V. Mukhomedzyanov, et al.
Published: (2025-04-01)

Direct comparison of cardioprotective effects of necroptosis inhibitors against global ischemia-reperfusion in the isolated rat heart
by: Yu. V. Dmitriev, et al.
Published: (2018-01-01)

Effects of Ellagic Acid and Berberine on Hind Limb Ischemia Reperfusion Injury: Pathways of Apoptosis, Pyroptosis, and Oxidative Stress
by: Esra Tekin, et al.
Published: (2025-03-01)

Cardioprotective diet: prevalence, associations and prevention reserves
by: N. S. Karamnova, et al.
Published: (2020-07-01)

Structural characterization and cardioprotective activities of natural polysaccharides from Apocynum venetum L
by: Wenli Xie, et al.
Published: (2025-06-01)

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review
by: Shang W, et al.
Published: (2025-07-01)

Cardiotoxic and Cardioprotective Effects of Methylene Blue in the Animal Model of Cardiac Ischemia and Reperfusion
by: Hezio Jadir Fernandes Junior, et al.
Published: (2024-11-01)

Early Administration of Bosentan in High‐Risk COVID‐19 Outpatients at Risk of Sarcopenia: A Randomized, Double‐Blind, Placebo‐Controlled Trial
by: Shaahin Shahbazi, et al.
Published: (2025-04-01)

ISCHEMIC PRECONDITIONING AND ITS CARDIOPROTECTIVE EFFECT IN POST-INTERVENTION CARDIAC REHABILITATION PROGRAMMES FOR PATIENTS WITH CORONARY HEART DISEASE
by: E. S. Karpova, et al.
Published: (2012-08-01)

Heart crosstalk with other organs and pharmacological strategies for cardioprotection
by: Zizhuo TU, et al.
Published: (2022-03-01)

Bioactive Compounds, Their Mechanisms of Action, and Cardioprotective Effects of Pomegranate (Punica granatum): A Comprehensive Review
by: Esha Saeed, et al.
Published: (2025-08-01)

Ultrafast ROS Scavenging Activity of Amur Maple Tree Extracts Confers Robust Cardioprotection for Myocardial Ischemia/Reperfusion Injury
by: Aoyang Pu, et al.
Published: (2025-05-01)

Cardioprotective Properties Of Xenon
by: A. I. Shpichko, et al.
Published: (2020-10-01)

Design, synthesis and biological evaluation of buthutin derivatives as cardioprotective agents
by: Yuan Liu, et al.
Published: (2025-02-01)

Cardioprotective and Anti‐Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence
by: Reza Eshraghi, et al.
Published: (2025-06-01)

CARDIOPROTECTIVE EFFECT OF TUMOR NECROSIS FACTOR ALPHA ANTAGONIST IN DOXORUBICIN MYOCARD TOXICITY
by: M. I. Popovich, et al.
Published: (2018-02-01)

Cardioprotective measures in patients with cardiovascular risk factors and polymorbidity
by: article Editorial
Published: (2022-10-01)

Cardioprotection Through Pharmacological Activation of Sirtuin 5 in a Murine Model of Acute Myocardial Infarction
by: Castiello C, et al.
Published: (2025-06-01)

Increase of Cardioprotective Effectiveness of Remote Ischemic Preconditioning during Cardiac Surgery
by: A. M. Radovskiy, et al.
Published: (2022-02-01)

Evaluation of the cardioprotective potential of hydroethanolic extract of Koenigia polystachya L. (Qiú xù liǎo) leaves against isoproterenol-induced myocardial infarction in rats
by: Arunabh Arandhara, et al.
Published: (2025-06-01)

Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
by: Hamdi Nsairat, et al.
Published: (2025-08-01)

MODERN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
by: D. V. Preobrazhensky, et al.
Published: (2009-12-01)

Modern pharmaceutical treatment of pulmonary arterial hypertension
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Evaluation of the cardioprotective activity of cardiac cryoextract in an adrenaline-induced myocardiodystrophy model based on oxidative stress markers
by: М.О. Chyzh, et al.
Published: (2025-04-01)

Analysis of the effectiveness of different cardioprotection methods in mitral valve repair in low left ventricular ejection fraction
by: D.V. Shabanov, et al.
Published: (2025-06-01)

Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model
by: Alejandra Bermúdez-Oria, et al.
Published: (2025-06-01)

Guardians of the sea: molecular and biochemical adaptations in sharks and whales for atherosclerosis resistance and their potential in human cardioprotection
by: Raymond Rubianto Tjandrawinata, et al.
Published: (2025-07-01)

Characterization of sweet potato flakes enriched with chia seeds: Nutritional profile, bioactive compounds, sensory attributes, and cardioprotective potential
by: Dipa Islam, et al.
Published: (2025-04-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01)

Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis
by: Runyu Liu, et al.
Published: (2025-07-01)

The effectiveness of succinate cardioprotection during vascular surgery in high cardiac risk patients
by: I. A. Kozlov, et al.
Published: (2024-02-01)

The Effect of “Carvacrol” on Ischemia-Reperfusion Injury in the Skeletal Muscles of Rats
by: Barış Mardin, et al.
Published: (2024-07-01)